Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Skin Diseases × Vemurafenib × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 3 Skin Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Skin Diseases 1 Leukemia, Hairy Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Aminolevulinic Acid 2 encorafenib 1 binimetinib 1 Vemurafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01909453 2026-02-27

COLUMBUS

Pfizer

Phase 3 Completed

921 enrolled 48 charts 1 FDA

Melanoma, Neoplasm Metastasis, Neoplasms, Skin Diseases, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡